2021
OTHR-06. PACS Lesion Tracking Tool provides real time automatic information on brain tumor metastasis growth curves and RECIST criteria
Jang B, Lin M, Owens R, Bousabarah K, Mahajan A, Fadel S, Ikuta I, Tocino I, Aboian M. OTHR-06. PACS Lesion Tracking Tool provides real time automatic information on brain tumor metastasis growth curves and RECIST criteria. Neuro-Oncology Advances 2021, 3: iii15-iii15. DOI: 10.1093/noajnl/vdab071.061.Peer-Reviewed Original ResearchFirst brain MRIRECIST evaluationRECIST criteriaPatient managementBrain MRIResponse Evaluation CriteriaRadiology reportsBrain MRI studiesAdditional useful informationPost-gadolinium sequencesRECIST outcomeStable diseaseBrain metastasesClinical responsePartial responseProgressive diseaseComplete responseRadiologic impressionNew lesionsIntracranial metastasesClinical differencesTarget lesionsTreatment responseMRI studiesLesion size
2020
A rare case of lupoid leishmaniasis defying diagnosis for a decade
Gehlhausen J, Sibindi C, Ko CJ, Grant M, Zubek A. A rare case of lupoid leishmaniasis defying diagnosis for a decade. Journal Of Cutaneous Pathology 2020, 47: 1054-1057. PMID: 32623733, DOI: 10.1111/cup.13793.Peer-Reviewed Case Reports and Technical NotesConceptsCutaneous leishmaniasisGranulomatous rosaceaPolymerase chain reactionFacial plaquesLupoid leishmaniasisMultiple medical therapiesAcid-fast bacilliExtensive travel historyStandard histopathologic examinationMedical therapyNew lesionsMultiple biopsiesRare presentationHistopathologic examinationGranulomatous diseaseTuberculoid granulomasUltimate diagnosisRare caseSustained improvementEndemic areasSpecial stainsTravel historySarcoidosisCommon diseaseRosaceaResponse criteria for intratumoral immunotherapy in solid tumors: ItRECIST.
Goldmacher G, Khilnani A, Andtbacka R, Luke J, Hodi F, Marabelle A, Harrington K, Perrone A, Tse A, Madoff D, Schwartz L. Response criteria for intratumoral immunotherapy in solid tumors: ItRECIST. Journal Of Clinical Oncology 2020, 38: 3141-3141. DOI: 10.1200/jco.2020.38.15_suppl.3141.Peer-Reviewed Original ResearchLesion responseResponse assessmentIntratumoral immunotherapySolid tumorsTarget lesion responseModification of therapyResponse Evaluation CriteriaRoutine clinical practiceOverall response assessmentUnique treatment strategyInjected lesionsIT drugsRECIST 1.1Immunotherapy trialsNew lesionsTumor burdenMetastatic melanomaTrial protocolClinical trialsInitial progressionTreatment strategiesTherapeutic modalitiesLesion assessmentNadir valuesTreatment evolves
2019
67 Appraisal of Follow-up Protocols and Outcomes of High Risk Pancreatic Cancer Surveillance Programs: A Systematic Review and Meta-Analysis
Chhoda A, Mukherjee E, Wattamwar K, Kastrinos F, Farrell J. 67 Appraisal of Follow-up Protocols and Outcomes of High Risk Pancreatic Cancer Surveillance Programs: A Systematic Review and Meta-Analysis. The American Journal Of Gastroenterology 2019, 114: s40-s41. DOI: 10.14309/01.ajg.0000589800.17291.ef.Peer-Reviewed Original ResearchHigh-risk individualsCross-sectional imagingEndoscopic ultrasoundPancreatic cancerDiagnostic rateSectional imagingSystematic reviewPt-yrNew lesionsBaseline imagingAdvanced pathologyCumulative progression rateCancer Surveillance ProgramOptimal imaging modalityPre-existing abnormalitiesSignificant differencesOutcomes of interestRandom-effects modelFirst systematic reviewUncontrolled studiesProspective studySubgroup analysisSurveillance protocolHistologic diagnosisProgression rate
2018
Paradoxical Reaction in a Patient with Co-Occurring Tuberculous Meningitis and Pott’s Disease
Robledo-Gil T, Harada K, Ikuta I, Villanueva M. Paradoxical Reaction in a Patient with Co-Occurring Tuberculous Meningitis and Pott’s Disease. American Journal Of Case Reports 2018, 19: 699-704. PMID: 29907737, PMCID: PMC6034555, DOI: 10.12659/ajcr.909194.Peer-Reviewed Case Reports and Technical NotesConceptsAppropriate anti-tuberculosis therapyHIV-seronegative patientsLow TB prevalenceParadoxical reactionTB prevalencePott's diseaseHIV-seronegative individualsTimely clinical managementFull neurologic recoveryAnti-tuberculosis therapyAppropriate diagnostic approachATT regimenRadiological worseningTB meningitisTransient diplopiaNeurologic recoveryClinical improvementHIV-seropositiveTuberculous meningitisRadiologic changesSuch patientsBack painNew lesionsClinical findingsClinical symptoms
2017
TBCRC 022: Phase II trial of neratinib + capecitabine for patients (Pts) with human epidermal growth factor receptor 2 (HER2+) breast cancer brain metastases (BCBM).
Freedman R, Gelman R, Melisko M, Anders C, Moy B, Blackwell K, Connolly R, Niravath P, Van Poznak C, Puhalla S, Farooq S, Cropp A, Cotter C, Liu M, Krop I, Nangia J, Tung N, Wolff A, Winer E, Lin N. TBCRC 022: Phase II trial of neratinib + capecitabine for patients (Pts) with human epidermal growth factor receptor 2 (HER2+) breast cancer brain metastases (BCBM). Journal Of Clinical Oncology 2017, 35: 1005-1005. DOI: 10.1200/jco.2017.35.15_suppl.1005.Peer-Reviewed Original ResearchBreast cancer brain metastasesObjective response rateCombination of neratinibCentral nervous system (CNS) objective response rateCNS objective response rateNeurologic signs/symptomsGrade 3 toxicityGrade 4 toxicityMedian age 51Cancer brain metastasesPhase II trialSigns/symptomsEvidence-based treatmentsNon-CNS lesionsCNS progressionPrior lapatinibPrior WBRTPrimary endpointProtocol therapyBrain metastasesII trialCNS lesionsNew lesionsMedian numberBrain MRI
2016
Double balloon protection during carotid artery stenting for vulnerable carotid stenosis reduces the incidence of new brain lesions
Nakazaki M, Nonaka T, Takahashi A, Yonemasu Y, Nomura T, Onda T, Honda O, Hashimoto Y, Ohnishi H, Sasaki M, Daibo M, Honmou O. Double balloon protection during carotid artery stenting for vulnerable carotid stenosis reduces the incidence of new brain lesions. Acta Neurochirurgica 2016, 158: 1377-1386. PMID: 27138330, DOI: 10.1007/s00701-016-2816-2.Peer-Reviewed Original ResearchConceptsDouble balloon protectionCarotid artery stentingDistal balloon protectionDistal filter protectionBalloon protectionCarotid stenosisNew lesionsFilter protectionDistal protectionDiffusion-weighted imaging studiesNew brain lesionsProximal balloon occlusionResultsSixty-four patientsIndependent significant factorsPosterior cervical musclesLogistic regression analysisT1-weighted imagesIschemic complicationsEmbolic complicationsArtery stentingBalloon occlusionCervical musclesDWI findingsTarget lesionsOdds ratio
2013
Challenges in cardiac device innovation: is neuroimaging an appropriate endpoint? Consensus from the 2013 Yale-UCL Cardiac Device Innovation Summit
Meller SM, Baumbach A, Voros S, Mullen M, Lansky AJ. Challenges in cardiac device innovation: is neuroimaging an appropriate endpoint? Consensus from the 2013 Yale-UCL Cardiac Device Innovation Summit. BMC Medicine 2013, 11: 257. PMID: 24330754, PMCID: PMC4029193, DOI: 10.1186/1741-7015-11-257.Peer-Reviewed Original ResearchConceptsTranscatheter aortic valve implantationAortic valve implantationLesion volumeCerebral eventsValve implantationNew lesionsClinical studiesSurrogate endpointsAppropriate endpointsPrimary efficacy endpointDiffusion-weighted magnetic resonance imagingCerebral protection devicesUseful surrogate endpointTotal lesion volumeMagnetic resonance imagingSample size limitationsEfficacy endpointClinical outcomesDevice successOngoing trialsNeurological protectionClinical eventsResonance imagingMRI valuesConsensus opinionClinical implications for diffusion‐weighted MRI brain lesions associated with transcatheter aortic valve replacement
Meller SM, Baumbach A, Brickman AM, Lansky AJ. Clinical implications for diffusion‐weighted MRI brain lesions associated with transcatheter aortic valve replacement. Catheterization And Cardiovascular Interventions 2013, 83: 502-508. PMID: 23460315, DOI: 10.1002/ccd.24904.Peer-Reviewed Original ResearchConceptsTranscatheter aortic valve replacementAortic valve replacementSilent strokeValve replacementCerebral embolic protection devicesDiffusion-weighted magnetic resonance imagingEmbolic protection devicesCerebral protection devicesMRI brain lesionsPotential therapeutic optionQuality of lifeLong-term cognitive consequencesMagnetic resonance imagingNeurological complicationsAortic stenosisImproved survivalNew lesionsEmbolic lesionsTherapeutic optionsBrain lesionsRisk candidatesCognitive declineResonance imagingClinical implicationsLesions
2012
Anti-PD-1 (BMS-936558, MDX-1106) in patients with advanced solid tumors: Clinical activity, safety, and a potential biomarker for response.
Topalian S, Brahmer J, Hodi F, McDermott D, Smith D, Gettinger S, Taube J, Drake C, Pardoll D, Antonia S, Spigel D, Atkins M, Lawrence D, McDonald D, Jure-Kunkel M, Korman A, Kollia G, Gupta A, Wigginton J, Sznol M. Anti-PD-1 (BMS-936558, MDX-1106) in patients with advanced solid tumors: Clinical activity, safety, and a potential biomarker for response. Journal Of Clinical Oncology 2012, 30: cra2509-cra2509. DOI: 10.1200/jco.2012.30.18_suppl.cra2509.Peer-Reviewed Original ResearchPD-1/PD-L1 pathwayPD-L1 pathwayPotential predictive biomarkersBMS-936558Predictive biomarkersNon-small cell lung cancerPre-treatment tumor biopsiesCastrate-resistant prostate cancerCo-inhibitory receptorsPD-L1 expressionPD-1 ligandsCell lung cancerOverall tumor burdenActivated T cellsCohort expansionEvaluable ptsRECIST 1.0Advanced NSCLCMedian durationDeath-1PD-1PD-L1Therapy cyclesNew lesionsTumor burden
2011
Acute Perfusion and Diffusion Abnormalities Predict Early New MRI Lesions 1 Week After Minor Stroke and Transient Ischemic Attack
Asdaghi N, Hameed B, Saini M, Jeerakathil T, Emery D, Butcher K. Acute Perfusion and Diffusion Abnormalities Predict Early New MRI Lesions 1 Week After Minor Stroke and Transient Ischemic Attack. Stroke 2011, 42: 2191-2195. PMID: 21737809, DOI: 10.1161/strokeaha.110.611376.Peer-Reviewed Original ResearchConceptsTransient ischemic attackBaseline DWI lesion volumeDWI lesion volumeIschemic attackDWI lesionsMinor strokeLesion volumeDay 7New lesionsPerfusion deficitsDiffusion-weighted imaging (DWI) lesion volumeDay 30Perfusion-weighted imaging lesionFluid-attenuated inversion recovery lesionsAcute DWI lesionsBaseline DWI lesionImaging Lesion VolumeNew DWI lesionsNew ischemic lesionsNew lesion developmentLesions 1 weekPerfusion-weighted imagingAcute perfusionBaseline DWINew infarcts
2005
Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation
Takebayashi H, Kobayashi Y, Mintz GS, Carlier SG, Fujii K, Yasuda T, Moussa I, Mehran R, Dangas GD, Collins MB, Kreps E, Lansky AJ, Stone GW, Leon MB, Moses JW. Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation. The American Journal Of Cardiology 2005, 95: 498-502. PMID: 15695138, DOI: 10.1016/j.amjcard.2004.10.020.Peer-Reviewed Original ResearchConceptsSirolimus-eluting stent implantationTarget vessel failureIntravascular ultrasound evaluationMinimum stent areaIntravascular ultrasound assessmentStent restenosesNew stenosisNew lesionsUltrasound evaluationNegative remodelingStent implantationUltrasound assessmentPlaque areaStent areaStent failureLesionsRestenosesVessel failureFailureThrombosesStenosisPatients
1998
Efficacy of Coronary Stenting Versus Balloon Angioplasty in Small Coronary Arteries fn1fn1This study was supported in part by a grant from Johnson & Johnson Interventional Systems, Inc., Warren, New Jersey.
Savage M, Fischman D, Rake R, Leon M, Schatz R, Penn I, Nobuyoshi M, Moses J, Hirshfeld J, Heuser R, Baim D, Cleman M, Brinker J, Gebhardt S, Goldberg S, Investigators F. Efficacy of Coronary Stenting Versus Balloon Angioplasty in Small Coronary Arteries fn1fn1This study was supported in part by a grant from Johnson & Johnson Interventional Systems, Inc., Warren, New Jersey. Journal Of The American College Of Cardiology 1998, 31: 307-311. PMID: 9462572, DOI: 10.1016/s0735-1097(97)00511-1.Peer-Reviewed Original ResearchMeSH KeywordsAngioplasty, Balloon, CoronaryChi-Square DistributionCohort StudiesCoronary AngiographyCoronary DiseaseCoronary VesselsDisease-Free SurvivalElective Surgical ProceduresEquipment DesignFemaleFollow-Up StudiesHumansLinear ModelsMaleMiddle AgedRecurrenceStentsSurvival RateTreatment OutcomeUnited StatesUnited States Food and Drug AdministrationConceptsElective stent placementBalloon angioplastyCoronary arteryStent placementElective stent implantationJohnson Interventional SystemsPostprocedural lumen diameterPrimary end pointEvent-free survivalClinical event ratesSmall coronary arteriesQuantitative coronary angiographyPalmaz-Schatz stentsAngioplasty groupAngiographic characteristicsCoronary angiographyClinical outcomesNew lesionsProcedural successDiameter stenosisStent groupStent implantationAbrupt closurePatientsAngioplasty
1984
Regional isolated perfusion of high risk melanoma of the extremities with imidazole carboxamide.
Ariyan S, Mitchell M, Kirkwood J. Regional isolated perfusion of high risk melanoma of the extremities with imidazole carboxamide. Journal Of The American College Of Surgeons 1984, 158: 238-42. PMID: 6701736.Peer-Reviewed Original ResearchConceptsRegional isolated perfusionIntransit metastasesIsolated perfusionSerum glutamic-oxalacetic transaminase levelFirst postoperative dayGlutamic oxalacetic transaminase levelHigh-risk melanomaTransaminase levelsPostoperative daySubcutaneous metastasesFourth patientNew lesionsFifth patientRisk melanomaImidazole carboxamidePatientsPerfused extremitySymptoms of toxicityValuable drugMetastasisExtremitiesMelanomaPerfusionMonthsDecarbazine
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply